DOCSLIB.ORG

Realindex Australian Share Fund

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Realindex Australian Share Fund Realindex Australian Share Fund Fact sheet - 31 Aug 2015 Fund strategy Fund facts The Realindex Australian Share Fund uses the RAFI® methodology in the Benchmark S&P / ASX 200 Accumulation Index construction of its portfolios which selects and weights companies Funds under management $2800.1 million according to their economic footprint defined by fundamental measures of Inception Date 17 November 2008 company size (sales, cash flow, book value and dividends). The portfolio is further enhanced by applying additional factors such as quality of earnings and debt coverage. Commentary The Realindex Australian Shares Fund returned -7.39% (gross of fees) during August 2015 outperforming the S&P/ASX 200 Accumulation Index which returned -7.79% (its worst monthly performance since October 2008). Value (-7.3%) slightly outperformed Growth (-8.0%) during the month, extending the longer-term outperformance trend (-2.4% vs. -6.1%, 12 months to 31 August 2015). This outcome is typically favourable for portfolio performance, given the Value tilt inherent in the Fundamental Indexation methodology. The Materials sector (-5.2%) was the top contributor to relative performance during the month, driven by overweight holdings in steel companies Sims Metal Management (+21.4%) and BlueScope Steel (+18.7%). Sims reported a better-than-expected FY15 result, while BlueScope committed to $200m cost out by FY17, which was well received by investors. An overweight holding in Spark New Zealand (+13.0%) led the portfolio’s outperformance in the Telecommunications sector (-8.3%). Spark rallied after announcing positive earnings growth and an annual dividend increase at its FY15 results. Spark was the top contributor to relative performance across the portfolio at a company level. In the Consumer Staples sector (-4.1%), an overweight holding in Wesfarmers (-1.6%) drove outperformance. Wesfarmers, which owns the Coles chain of supermarkets, performed well after delivering a solid set of FY15 results. Underweight exposure to a relatively strong Health Care sector (- 5.8%) was the main detractor at a sector level. Biotechnology company Sirtex Medical (+12.5%), which is not held in the portfolio, rallied after posting record sales and net profit. The portfolio has an underweight exposure to Australia’s Financials sector (-9.6%), and thus benefitted from weakness in the ‘big four’ banks; Commonwealth Bank (-11.4%), ANZ ( 14.5%), NAB (-14.5%) and Westpac (-10.8%). These gains were largely offset however by underweight holdings elsewhere in the sector, with Medibank Private (+11.5%), Scentre Group ( 1.2%) and Magellan Financial Group (+5.3%) all faring significantly better. The portfolio continued to offer a valuation discount to the market-cap benchmark, as measured by price-to-book (2.1x vs. 2.3x) and price to sales (2.1x vs. 2.6x), as well as a dividend yield higher than the benchmark (5.0% vs. 4.8%). % figures in parenthesis show total return in Australian dollars from 31 July 2015 to 31 August 2015, unless otherwise noted. Since Gross performance 1 month 3 month 6 month 1 year 2 year 3 year 5 year inception Realindex Australian Share Fund -7.39% -9.64% -10.49% -4.49% 4.60% 11.37% 8.80% 11.23% ASX 200 Accum -7.79% -8.84% -10.09% -3.16% 5.26% 11.25% 8.16% 10.17% Outperformance 0.40% -0.80% -0.40% -1.33% -0.66% 0.12% 0.64% 1.06% Top 10 holding comparison ASX 200 ASX 200 as at 31 Aug 2015 Fund Accum Active Weight Sector Holding comparison Fund Accum Active Weight BHP Billiton Limited 7.45% 6.07% 1.39% Energy 5.31% 4.48% 0.83% Commonwealth Bank of Australia 7.20% 9.57% -2.37% Materials 18.09% 14.45% 3.63% Westpac Banking Corporation 6.79% 7.43% -0.65% Industrial 8.63% 7.48% 1.15% Telstra Corporation Limited 5.41% 5.29% 0.12% Consumer Discretionary 5.59% 4.26% 1.33% National Australia Bank Limited 4.99% 6.12% -1.13% Consumer Staples 9.61% 6.99% 2.62% Wesfarmers Limited 4.50% 3.43% 1.07% Healthcare 3.72% 6.45% -2.73% Woolworths Ltd 3.33% 2.51% 0.82% A-REIT 5.82% 7.46% -1.63% Rio Tinto Limited 2.05% 1.60% 0.44% Financial-x-A-REIT 33.93% 39.70% -5.77% Woodside Petroleum Ltd 1.88% 1.72% 0.16% Information Technology 0.45% 0.68% -0.23% CSL Limited 1.59% 3.21% -1.62% Telecoms 6.56% 5.76% 0.80% Utilities 2.30% 2.30% 0.00% Top 5 relative contributors Value added Top 5 relative detractors Value lost Spark New Zealand Limited 0.09% Medibank Private Ltd -0.06% Commonwealth Bank of Australia 0.09% Scentre Group -0.04% Leighton Holdings Limited 0.07% Transurban Group Ltd. -0.04% Wesfarmers Limited 0.07% Sydney Airport -0.04% Sims Metal Management Limited 0.06% Downer EDI Limited -0.03% Contact To find out more, please contact us on 1300 809 204 or email [email protected]. Disclaimer Realindex Investments Pty Limited ABN 24 133 312 017 AFSL 335381. The Realindex Australian Share Fundoption (Fund) described in this document is offered by Colonial First State Investments Limited ABN 98 002 348 352, AFSL 232 468. This document is intended to provide general information only. You should assess whether the information is appropriate to you before making an investment decision. The performance figures used in this document are sourced from the Fund’s relevant benchmark index and from actual performance figures achieved before fees and expenses. Past performance is no indication of likely future performance. The fees payable by investors in the Fund may be negotiated and can differ between investors. For this reason the performance figures used in this document are shown before fees and costs. Investors should have regard to the Information Memorandum (available by contacting the Realindex team on 1300 809 204) or their negotiated fee agreement for further information on the fees and costs. Neither the Commonwealth Bank of Australia nor any of its subsidiaries guarantees or stands behind the performance of the Fund or the repayment of capital. An investment in the Fund is not a deposit or liability of the Bank and is subject to investment risk including loss of income and capital. RAFI and Fundamental Index are trademarks of Research Affiliates LLC, and are used with permission. Patent pending: WO 2005/076812, WO 2007/078399. Research Affiliates, LLC, is a U.S. Securities and Exchange Commission registered investment advisor. Research Affiliates, LLC and its related entities do not warrant the accuracy of the information provided herein, either expressed or implied, for any particular purpose. 0.
Load more

Recommended publications
  • 2017 Annual Report 1 I Sirtex 2017 Highlights
    2017 ANNUAL REPORT 1 I SIRTEX 2017 HIGHLIGHTS DOSES SOLD 2017 12,578 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 CONTENTS ABOUT SIRTEX 03 2017 FINANCIAL SUMMARY Sirtex Medical Limited is an Australian- 05 CHAIRMAN’S REPORT based global healthcare business working to 09 CHIEF EXECUTIVE OFFICER’S REPORT improve outcomes for people with cancer. 18 ENVIRONMENTAL, SOCIAL AND Our lead product is a targeted radiation GOVERNANCE therapy known as SIR-Spheres® Y-90 resin 22 BOARD OF DIRECTORS microspheres. It is available in more than 23 KEY MANAGEMENT PERSONNEL 40 countries, within over 1,090 certified hospitals to treat patients with 24 FINANCIAL REPORT inoperable liver cancer. Our business revolves around helping medical professionals understand and use our product to improve clinical outcomes and the quality of life for people with liver cancer. While at the same time, we work closely with government and private payers to ensure our patients receive the appropriate reimbursement for our product. We are challenging established practices and developing innovative new therapies that promise to improve the health and lives of many people suffering from cancer or other diseases. Our ongoing success is based on a commitment to serving our customers, professionalism, continuous improvement and innovation. ANNUAL REPORT 2017 I 2 DOSE SALES 12,578 +5.4% REVENUE $234.3m +0.8% NET LOSS AFTER TAX $26.3m -149.0% THE AMERICAS EUROPE, MIDDLE ASIA PACIFIC EAST, AFRICA Boston, United States Frankfurt,
    [Show full text]
  • Sigma Emerging Companies Strategy
    Sigma Emerging Companies Strategy Quarterly update as at 30 June 2017 Since Quarter FYTD 1 year 3 years 5 years Inception^ % % % % p.a. % p.a. % p.a. Sigma Emerging Companies Strategy* (1.3) 20.9 20.9 5.7 8.5 6.5 S&P/ASX Small Ord. Acc. Index (0.3) 7.0 7.0 7.1 5.7 1.7 Value added (detracted) (1.0) 13.9 13.9 (1.4) 2.8 4.8 *Gross Performance. Past performance is not a reliable indicator of future performance. ^Since Inception: 1 January 2010 Key points • Small Cap “value opportunity” clearly evident as traditional metrics remain compelling • Cyclical sectors expected to benefit as earnings bottom and risk appetite increases • Fund positioned for cyclical re-rating and away from lower return defensives Individual stock performance of note • The absence of Mayne Pharmaceuticals (-24%), Sigma The Sigma Emerging Companies Strategy (Strategy) Pharmaceuticals (32%) and Myer (-31%) contributed to underperformed a falling small cap market in the June quarter. performance in a relative sense. Stock selection was important, and generally speaking over Strategy performance was driven negatively by: the last 6 months we have seen the performance tilt away from the value recovery we saw during the first half of the financial • Infigen (-25%), lower following an earnings downgrade due year. A recovery in high PE stocks and the move towards to poor wind conditions in the final quarter which impacted more defensive positioning has proven to be a drag on the power generation. We view this as a one-off event and portfolio.
    [Show full text]
  • Australian Listed Equities: Weekly Share Market Wrap
    Australian Listed Equities: Weekly Share Market Wrap Total Shareholder Returns as at 15 April 2016 Price 1 week 1 month 6 months 1 year 2 years 3 years 5 years 10 years 10 years Ticker Stock Name $ % % % % % p.a. % p.a. % p.a. % p.a. ranking A2M The A2 Milk Company 1.665 -4.31 2.78 134.51 208.33 - - - - - ABC Adelaide Brighton 5.10 -1.16 6.03 26.15 17.04 19.09 19.37 12.82 10.84 34 ABP Abacus Property Group 3.10 2.99 5.08 -0.47 12.76 20.70 17.15 11.90 -1.96 105 AFI Australian Foundat. 5.53 0.18 -1.60 -4.25 -7.23 0.42 5.09 6.71 5.22 58 AGL AGL Energy Limited. 18.24 -0.65 0.55 15.71 25.25 14.52 10.63 9.90 6.32 53 AHG Automotive Holdings. 3.85 -0.52 -3.78 -1.13 -2.98 4.35 4.94 12.70 14.45 22 AIA Auckland Internation 5.75 -1.88 0.45 25.03 28.95 28.14 37.37 30.93 14.31 23 AIO Asciano Limited 8.84 1.14 -1.67 13.83 38.00 31.68 21.04 13.79 - - AIZ Air New Zealand 2.70 -0.37 9.76 4.19 3.16 27.56 39.16 31.16 13.06 24 ALL Aristocrat Leisure 10.12 4.01 1.50 14.85 23.98 45.00 42.39 29.35 -1.72 102 ALQ ALS Limited 4.38 15.57 1.15 -16.29 -1.83 -16.66 -16.64 -6.48 10.25 37 AMC Amcor Limited 14.76 1.17 4.53 15.59 5.97 25.73 23.23 20.98 11.71 29 AMP AMP Limited 5.79 5.46 2.84 3.13 -8.72 11.19 8.68 4.71 1.17 88 ANN Ansell Limited 19.68 13.30 14.42 3.31 -32.90 7.34 12.16 9.27 7.39 47 ANZ ANZ Banking Grp Ltd 23.85 7.05 -6.07 -13.17 -28.60 -9.52 0.33 6.22 3.50 72 AOG Aveo Group 3.30 0.30 4.10 16.20 24.07 30.19 38.74 -1.59 -9.34 119 APA APA Group 8.71 0.46 5.83 1.14 -1.03 22.97 17.57 21.10 11.78 28 APE AP Eagers Limited 10.00 4.06 -0.58 0.99 24.34 45.68 30.49
    [Show full text]
  • Sep Tem B Er
    4 201 Quarterly Newsletter September FML S In this quarterly edition we review performance and attribution. We profile GBST Holdings and IProperty Group. Offshore we take a look at QE and US Energy. We also consider how Technology for the Ages changes with each generation. Photo: School holidays - no worries, surfing for a 9 year old maybe as good as it gets and no technology needed. Selector Funds Management Limited ACN 102756347 AFSL 225316 Level 3, 10 Bridge Street Sydney NSW 2000 Australia Tel 612 8090 3612 www.selectorfund.com.au selector About Selector We are a boutique fund manager and we have a combined experience of over 150 years. We believe in long term wealth creation and building lasting relationships with our investors. Our focus is stock selection. Our funds are high conviction, concentrated and index unaware. As a result we have low turnover and produce tax effective returns. First we identify the best business franchises with the best management teams. Then we focus on valuations. Please forward to us contact details if you would like future newsletters to be emailed to family, friends or business colleagues. Selector Funds Management Limited ACN 102756347 AFSL 225316 Level 3, 10 Bridge Street Sydney NSW 2000, Australia Telephone 612 8090 3612 Web www.selectorfund.com.au selector September 2014 Selector High Conviction Equity Fund Quarterly Newsletter #45 Dear Investor, With the company reporting season over for another year, investor attention has quickly shifted to the road ahead. Here the simple message, proceed with caution, has been top of mind and for good reason.
    [Show full text]
  • ASD NTA & Allotment Notice
    Friday, 8 March 2019 ASD NTA & Allotment Notice Smartshares Limited would like to report details of the Units on Issue for the Australian Dividend Fund (ASD) as at 7 March 2019. Units on Issue: 15,304,541 Units Allotted/(Redeemed): - Net Tangible Assets (NTA): $1.61250 Tracking Difference: 1.04% The objective of the Australian Dividend Fund (ASD) is to provide a return that closely matches the return on the S&P/ASX Dividend Opportunities Index. The S&P/ASX Dividend Opportunities Index comprises the 50 highest yielding common stocks from the Australian equity market. The following companies are currently held in the Fund: Code Security description ABC Adelaide Brighton Ltd. APA APA Group API Australian Pharmaceutical Industries Ltd. ASL Ausdrill Ltd. AST AusNet Services Ltd. ASX ASX Ltd. AWC Alumina Ltd. BEN Bendigo and Adelaide Bank Ltd. CBA Commonwealth Bank of Australia CCL Coca-Cola Amatil Ltd. CTX Caltex Australia Ltd. CWN Crown Resorts Ltd. DLX DuluxGroup Ltd. DOW Downer EDI Ltd. ECX Eclipx Group Ltd. FMG Fortescue Metals Group Ltd. GUD G.U.D. Holdings Ltd. GWA GWA Group Ltd. HVN Harvey Norman Holdings Ltd. IAG Insurance Australia Group Ltd. ILU Iluka Resources Ltd. ING Inghams Group Ltd. IPH IPH Ltd. JBH JB Hi-Fi Ltd. LLC Lendlease Group MFG Magellan Financial Group Ltd. MIN Mineral Resources Ltd. MMS McMillan Shakespeare Ltd. MQG Macquarie Group Ltd. MTS Metcash Ltd. NEC Nine Entertainment Co. Holdings Ltd. NHC New Hope Corporation Ltd. PDL Pendal Group Ltd. PMV Premier Investments Ltd. RIO Rio Tinto Ltd. www.smartshares.com RRL Regis Resources Ltd.
    [Show full text]
  • SIR-Spheres® Y-90 Resin Microspheres
    Manufacturer: US Sales Office: Sirtex Medical Limited Sirtex Medical Inc Level 33, 101 Miller Street, 300 Unicorn Park Drive, North Sydney NSW 2060, Australia Woburn MA 01801, USA Tel: +61 2 9964 8400 Tel: 1 888 474 7839 www.sirtex.com 4 Warnings • Some patients may experience gastric problems following treatment but H-2 blocking agents may 4.1 Non-Target Delivery of SIR-Spheres be used the day before implantation of SIR- microspheres Spheres microspheres and continued as needed to reduce gastric complications. Inadvertent delivery of SIR-Spheres microspheres to extra-hepatic structures such as the esophagus, • Many patients may experience abdominal pain SIR-Spheres® Y-90 resin stomach, duodenum, gallbladder or pancreas may immediately after administration of SIR-Spheres result in radiation injury to these structures. microspheres and pain relief may be required. microspheres Meticulous angiographic technique must be • SIR-Spheres microspheres demonstrated a mild (Yttrium-90 microspheres) employed to prevent the non-target delivery of SIR- sensitization potential when tested dermally in an Spheres microspheres to any extra-hepatic animal model. structures. 1 Description 4.2 Radioembolization Induced Liver 6 Clinical Trial Results SIR-Spheres microspheres consist of biocompatible microspheres containing yttrium-90 with a size Disease (REILD) In a randomized, controlled clinical trial, a total of 70 patients were studied in two arms, 34 patients with between 20 and 60 microns in diameter. Yttrium-90 Delivery of excessive radiation to the normal liver FUDR chemotherapy (control group), and 36 is a high-energy pure beta-emitting isotope with no parenchyma may result in REILD – see description patients with FUDR plus SIR-Spheres microspheres.
    [Show full text]
  • Smallco Investment Fund
    Smallco Investment Fund Quarterly Update 30 September 2014 SIF Portfolio Commentary SIF Performance Smallco Investment Fund (SIF) delivered 6.8% during the Return to 30 September 2014 September quarter and for the 12 months was up a solid 12.3%. During the quarter Iress, Isentia Group and Sirtex 3 months 6.8% Medical performed positively, while Carsales.com, Ozforex 1 year 12.3% Group and Macquarie Atlas Roads were negative 3 year p.a. 36.4% contributors. 5 year p.a. 22.5% For the September quarter the Small Ordinaries index was 10 year p.a. 13.6% modestly positive at 1.5% while for the year to 30 Since inception (31.10.00) p.a. 14.2% September it was down -0.1%. Value of $100,000 invested at inception $631,173 In general the Australian market had a solid reporting Fund returns calculated after all fees and expenses and based season and that was reflected in share prices during upon exit price and reinvestment of distributions. August, particularly for Industrial companies. However, towards the end of the quarter, the Australian and international markets became concerned about global political tensions – Ukraine, Iraq and Hong Kong – with a falling iron ore price having a significant negative impact on the Australian resources index. SIF Structure: by sector (look through) One of our major holdings is IRESS (IRE). SIF originally invested in IRE in 2002 when it had a market capitalisation of $260m. At the time we invested it was already the dominant provider of information systems to the professional equity market in Australia and New Zealand (ANZ).
    [Show full text]
  • 2020 Mid-Year Report
    NON-U.S. LITIGATION UPDATE / 2020 MID-YEAR REPORT The LIAISON NEW YORK | WASHINGTON, D.C. | DELAWARE LABATON.COM Contents and EXECUTIVE SUMMARY EXECUTIVE SUMMARY CONTENTS Labaton Sucharow is pleased to present The Liaison: 2020 Mid-Year Report. P 1 EXECUTIVE SUMMARY The Firm has been a pioneer in protecting clients’ interests in non- U.S. litigation. With its nearly 20 years of experience abroad, and deep P 2 TRENDS IN NON-U.S. SECURITIES CLASS relationships with law firms around the world, Labaton Sucharow ACTION LITIGATION has a unique perspective on investment-related issues and recovery opportunities outside the United States. Featured in this edition are: P 4 NOTEWORTHY DEVELOPMENTS P 4 Changes to the Landscape for • Recent settlements in non-U.S. securities matters; Securities Class Action in Australia • Noteworthy developments regarding securities litigation in Australia; P 7 A New Opportunity for U.S. Investors • Ramifications of the recent U.S. decision in the Toshiba class action; to Seek Recovery in the United States • Summary of the newly-proposed Westpac action in Australia; or Losses on Shares Abroad? • Updates on select pending non-U.S. securities actions; and • Deadlines for participation in non-U.S. actions and for the submission P 10 NEWLY ANNOUNCED MATTER: of settlement claims. WESTPAC BANKING CORPORATION We would be happy to provide more comprehensive assessments and P 11 ONGOING CASE STUDIES recommendations with regard to any of the topics discussed or highlighted P 12 Germany in The Liaison. P 12 The Netherlands P 13 United Kingdom With best regards, P 14 Denmark P 14 New Zealand Labaton Sucharow LLP P 15 Australia P 17 Japan P 18 Brazil P 19 CONTACT US The LIAISONPAGE 1 THE LIAISON Trends in Non-U.S.
    [Show full text]
  • Annual Report 2018 Sustainability Report 2018
    SUSTAINABILITY REPORTANNUAL REPORT 2018 SIMS METAL MANAGEMENT LIMITED SUSTAINABILITY REPORT 2018 ABOUT THIS REPORT Stewards of our world’s limited resources... ABOUT SIMS METAL MANAGEMENT ALIGNING TO INVESTOR INTEREST We at Sims Metal Management are proud Over the past year, our investors of our role as stewards of our world’s have increasingly asked about Sims’ Recycling for posture and performance in the areas >100 years limited resources for over 100 years. As a global leader of metals and electronics of environmental, social and corporate recycling we play an intrinsic role in the governance (ESG). As the graphic below circular economy, by keeping resources in illustrates, Sims is very much aligned with use as long as possible, extracting the the circular economy – where materials maximum value from those resources remain in useful life for as long as possible. >250 facilities We discuss this in detail later in this report. including JVs while in use, and then recovering and regenerating products and materials at In June 2017, the G20 Financial Stability the end of their useful life. Our efforts Board’s Task Force on Climate-Related contribute to the sustainable future of Financial Disclosures (TCFD) released its our world. final recommendations on the disclosure Operations in Our core businesses are: of the risks and opportunities as we 18 countries transition into a lower carbon economy. • Metals Recycling - As the world’s We have organized this report around leading publicly listed metals recycler, the four main categories of the TCFD Sims buys and sells ferrous and recommendations. (Governance, Strategy, non-ferrous recycled metals.
    [Show full text]
  • SIMS GROUP LIMITED Annual REPORT 2008 SIM S G R O U P L IM IT E D a N N U a L RE P O R T 2 0
    SIMS GROUP LIMITED GROUP SIMS ANN U a L REPORT2008 L ThE average motor vEhIcle SIMS GROUP LIMITED Lasts 13.5 yEars anD comprises annUaL report 2008 approximately 15,000 IndividuaL Parts, Of whIch 80% are potentially recOverable. Approximately 68% Of a vEhIcle’S Parts by weighT aRE steel, followed by plastic (9%) anD nOn ferrous metals (8%), with ThE remaInder rubber, glass anD other materials. www.simsMM.cOM finanCiaL Summary Corporate DireCtory For the year ended 30 June 2008 SeCuritieS exChange LiSting Shareholder enquirieS The Company’s ordinary shares are quoted Enquiries from investors regarding their $7.67 b 38% $433m 81% 306¢ 60% 130¢ 8% on the Australian Securities Exchange under share holdings should be directed to: the ASX Code ‘SGM’. Computershare Investor Services Pty Limited TotaL REvEnue Profit after Tax EaRnIngs per ShaRE DIvidends per Share The Company’s American Depositary Shares Level 3 (ADSs) are quoted on the New York Stock 60 Carrington Street Exchange under the symbol ‘SMS’. The Company Sydney NSW 2000 has a Level II ADS program, and the Depositary Postal Address: is the Bank of New York Mellon Corporation. GPO Box 7045 ADSs trade under cusip number 829160100 Sydney NSW 2001 with each ADS representing one (1) ordinary Telephone: 1300 855 080 share. Further information and investor Facsimile: (02) 8235 8150 enquiries on ADSs may be directed to: Company SeCretarieS $181m 42% 14.6% 22% 10.9% 43% $8.02 72% The Bank of New York Mellon Corporation Frank Moratti Depositary Receipts Division Scott Miller Net caSh flowS Return
    [Show full text]
  • Business Leadership: the Catalyst for Accelerating Change
    BUSINESS LEADERSHIP: THE CATALYST FOR ACCELERATING CHANGE Follow us on twitter @30pctAustralia OUR OBJECTIVE is to achieve 30% of ASX 200 seats held by women by end 2018. Gender balance on boards does achieve better outcomes. GREATER DIVERSITY ON BOARDS IS VITAL TO THE GOOD GOVERNANCE OF AUSTRALIAN BUSINESSES. FROM THE PERSPECTIVE OF PERFORMANCE AS WELL AS EQUITY THE CASE IS CLEAR. AUSTRALIA HAS MORE THAN ENOUGH CAPABLE WOMEN TO EXCEED THE 30% TARGET. IF YOUR BOARD IS NOT INVESTING IN THE CAPABILITY THAT DIVERSITY BRINGS, IT’S NOW A MARKED DEPARTURE FROM THE WHAT THE INVESTOR AND BROADER COMMUNITY EXPECT. Angus Armour FAICD, Managing Director & Chief Executive Officer, Australian Institute of Company Directors BY BRINGING TOGETHER INFLUENTIAL COMPANY CHAIRS, DIRECTORS, INVESTORS, HEAD HUNTERS AND CEOs, WE WANT TO DRIVE A BUSINESS-LED APPROACH TO INCREASING GENDER BALANCE THAT CHANGES THE WAY “COMPANIES APPROACH DIVERSITY ISSUES. Patricia Cross, Australian Chair 30% Club WHO WE ARE LEADERS LEADING BY EXAMPLE We are a group of chairs, directors and business leaders taking action to increase gender diversity on Australian boards. The Australian chapter launched in May 2015 with a goal of achieving 30% women on ASX 200 boards by the end of 2018. AUSTRALIAN 30% CLUB MEMBERS Andrew Forrest Fortescue Metals Douglas McTaggart Spark Group Ltd Infrastructure Trust Samuel Weiss Altium Ltd Kenneth MacKenzie BHP Billiton Ltd John Mulcahy Mirvac Ltd Stephen Johns Brambles Ltd Mark Johnson G8 Education Ltd John Shine CSL Ltd Paul Brasher Incitec Pivot
    [Show full text]
  • Weekly Ratings, Targets, Forecast Changes
    Weekly Ratings, Targets, Forecast Changes Sep 03, 2018 By Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of eight major Australian and international stock brokers: Citi, Credit Suisse, Deutsche Bank, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose of broker rating correlation, Outperform and Overweight ratings are grouped as Buy, Neutral is grouped with Hold and Underperform and Underweight are grouped as Sell to provide a Buy/Hold/Sell (B/H/S) ratio. Ratings, consensus target price and forecast earnings tables are published at the bottom of this report. Summary Period: Monday August 27 to Friday August 31, 2018 Total Upgrades: 16 Total Downgrades: 24 Net Ratings Breakdown: Buy 40.93%; Hold 43.41%; Sell 15.67% Securities analysts in Australia are still issuing more recommendation downgrades than upgrades, but at least the gap between the two is narrowing noticeably. In contrast to prior weeks, both tables for the week ending Friday, 31st August 2018, are populated by stocks receiving multiple switches in stockbroker ratings. FNArena counted 16 upgrades and 24 downgrades pulling the ratio for the four weeks of August just below 1:2. Receiving multiple upgrades were ambitious gold miner Northern Star Resources (2x) and Regis Resources (gold and nickel) and Sims Metal Management (scrap) with the latter two enjoying three upgrades post results releases. Only six of the 16 upgrades involves a Buy rating. On the flipside,FNArena nutritional supplements provider Blackmores was downgraded three times during the week, of which two downgrades moved to Sell, while fruit and veggies grower Costa Group was downgraded twice, both to Neutral/Hold; troubled contractor RCR Tomlinson was also downgraded twice (one Sell only), while fresh Sell ratings fell upon the likes of Bega Cheese, WiseTech Global, Qube Holdings, Virgin Australia and Reliance Worldwide.
    [Show full text]